Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse Models
Do‐Yeon Kim, Jin‐Sun Park, Yea-Hyun Leem, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 16, Iss. 2, pp. 470-482
Closed Access | Times Cited: 19

Showing 19 citing articles:

Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases
Yu Xiang, Swapna Naik, Liyun Zhao, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1404-1445
Closed Access | Times Cited: 7
Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system
Zoë Donders, Iga Joanna Skorupska, Emily Willems, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117009-117009
Open Access | Times Cited: 7
Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases
Qi Li, Qinghong Liao, Shulei Qi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116386-116386
Closed Access | Times Cited: 6
The Emerging Role of Phosphodiesterases in Movement Disorders
Roberto Erro, Niccolò E. Mencacci, Kailash P. Bhatia
Movement Disorders (2021) Vol. 36, Iss. 10, pp. 2225-2243
Open Access | Times Cited: 38
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury
Carolyn Tallon, Silvia Picciolini, Seung‐Wan Yoo, et al.
Biochemical Pharmacology (2021) Vol. 194, pp. 114796-114796
Open Access | Times Cited: 27
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
Lara Cheslow, Matthew Byrne, Jessica Kopenhaver, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Stem-leaf saponins of Panax notoginseng attenuate experimental Parkinson's disease progression in mice by inhibiting microglia-mediated neuroinflammation via P2Y2R/PI3K/AKT/NFκB signaling pathway
Hui Wu, Chenyang Ni, Yu Zhang, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 43-53
Closed Access
Interpreting the Mechanism of Active Ingredients in Polygonati Rhizoma in Treating Depression by Combining Systemic Pharmacology and In Vitro Experiments
Xin Wei, Dan Wang, Jiajia Liu, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1167-1167
Open Access | Times Cited: 3
L-Type Ca2+ Channel Inhibition Rescues the LPS-Induced Neuroinflammatory Response and Impairments in Spatial Memory and Dendritic Spine Formation
Ji‐Eun Kim, Seong Gak Jeon, Ha-Ram Jeong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13606-13606
Open Access | Times Cited: 12
Inhibition of phosphodiesterase 10A by MP-10 rescues behavioral deficits and normalizes microglial morphology and synaptic pruning in a mouse model of FOXP1 syndrome
Henning Froehlich, Jing Wang, Ferdinand Althammer, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease
Tomasz Lenda, Krystyna Ossowska, Klemencja Berghauzen-Maciejewska, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174460-174460
Open Access | Times Cited: 10
Inhibition of PDE10A-Rescued TBI-Induced Neuroinflammation and Apoptosis through the cAMP/PKA/NLRP3 Pathway
Jin Huang, Tang Dang, Yiqiang Cao, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 6
Discovery of a highly specific 18F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination
Zhiwei Xiao, Huiyi Wei, Yi Xu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1963-1975
Open Access | Times Cited: 7
Inhibition of phosphodiesterase 10A mitigates neuronal injury by modulating apoptotic pathways in cold-induced traumatic brain injury
Mustafa Çağlar Beker, Mehmet Özgen Altıntaş, Emre Doğan, et al.
Molecular and Cellular Neuroscience (2024) Vol. 131, pp. 103977-103977
Closed Access
Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits
Erik H. Douma, Jesse Stoop, Matthijs V. R. Lingl, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access
Selectivity mechanism of inhibition towards Phosphodiesterase 1B and Phosphodiesterase 10A in silico investigation
Jianheng Li, Pengfei Song, Hanxun Wang, et al.
Computational Biology and Chemistry (2024) Vol. 115, pp. 108322-108322
Closed Access
Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway
Cheng Ju, Fang-Yu Yuan, Lu Wang, et al.
Neurobiology of Disease (2023) Vol. 177, pp. 105988-105988
Open Access | Times Cited: 1
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
Scott A. Waldman, Lara Cheslow, Matthew Byrne, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Comparison and optimization of transfection methods for human lymphoblast TK6 cell line
Akamu J. Ewunkem, Kyle Agee
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top